These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2465857)

  • 21. [Adjuvant interferon therapy in malignant melanoma].
    Mohr P
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):543-5. PubMed ID: 17537052
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel ATX-S10(Na) photodynamic therapy for human skin tumors and benign hyperproliferative skin.
    Takahashi H; Itoh Y; Nakajima S; Sakata I; Iizuka H
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):257-65. PubMed ID: 15379877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Photodynamic diagnosis and therapy in dermatology. Experience with use of TPPS4 in skin diseases].
    Jirásková M; Jirásek L; Stork J; Vosmík F; Jirsa M
    Cas Lek Cesk; 2003 Aug; 142(8):493-9. PubMed ID: 14626566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of interferons in the treatment of malignant neoplasms.
    Murren JR; Buzaid AC
    Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon.
    Greenway HT
    West J Med; 1994 Apr; 160(4):363. PubMed ID: 7517599
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of epidermal growths with solcoderm].
    Haim S; Cohen A
    Harefuah; 1983 Feb; 104(3):89-90. PubMed ID: 6352426
    [No Abstract]   [Full Text] [Related]  

  • 27. High-dose interferon versus GM2 vaccine in high-risk malignant melanoma.
    Wilson K
    J Clin Oncol; 2001 Dec; 19(23):4350. PubMed ID: 11731522
    [No Abstract]   [Full Text] [Related]  

  • 28. [2 years' experience with local treatment by 5-fluorouracil].
    Bouillenne JC
    Arch Belg Dermatol Syphiligr; 1970; 26(1):33-7. PubMed ID: 5519041
    [No Abstract]   [Full Text] [Related]  

  • 29. Photodynamic therapy in dermatology.
    Babilas P; Landthaler M; Szeimies RM
    Eur J Dermatol; 2006; 16(4):340-8. PubMed ID: 16935788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interferon in antitumoral chemotherapy].
    Soria M
    Recenti Prog Med; 1981 May; 70(5):494-523. PubMed ID: 6171850
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental research to clinical application of interferons].
    Imamishi J; Tanaka A
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal interferon therapy in malignant melanoma. Significant economies of interferon in an extracorporeal chamber.
    Langvad E; Hydén H; Petersen JK; Jordal R; Olsen G
    Arzneimittelforschung; 1980; 30(8):1245-6. PubMed ID: 6159905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Off-label uses of biologics in dermatology: interferon and intravenous immunoglobulin (part 1 of 2).
    Smith DI; Swamy PM; Heffernan MP
    J Am Acad Dermatol; 2007 Jan; 56(1):e1-54. PubMed ID: 17190617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon.
    Moore GE
    Surg Gynecol Obstet; 1981 Jul; 153(1):97-102. PubMed ID: 6166059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In skin changes often it is difficult to decide. Harmless growth or malignant tumor?].
    Neumaier J
    MMW Fortschr Med; 2004 Feb; 146(8):18-9. PubMed ID: 15346932
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferons.
    Mahajan BB; Kaur S
    Indian J Dermatol Venereol Leprol; 2015; 81(1):51-5. PubMed ID: 25566899
    [No Abstract]   [Full Text] [Related]  

  • 37. The interferons.
    Edwards L
    Dermatol Clin; 2001 Jan; 19(1):139-46, ix. PubMed ID: 11155578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of clinical interferon research in Japan.
    Yamazaki S
    Jpn J Med Sci Biol; 1983 Oct; 36(5):261-71. PubMed ID: 6199532
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of interferon therapy on the function of the peripheral blood granulocytes in patients with malignant diseases].
    Seidel J; von Wussow P; Naucke C; Stangel W; Mirkhani J; Behrmann M
    Beitr Infusionther Klin Ernahr; 1987; 18():272-5. PubMed ID: 2449890
    [No Abstract]   [Full Text] [Related]  

  • 40. The interferons. A clinician's view.
    Landow RK
    Dermatol Clin; 1988 Oct; 6(4):569-74. PubMed ID: 2465857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.